Episurf Medical’s Prof. Leif Ryd to be amongst faculty at Orthopaedic Summit 2022: Evolving Techniques
Episurf Medical (Nasdaq: EPIS B) today announces that the company's founder and board member Prof. Leif Ryd will participate in the Orthopaedic Summit 2022: Evolving Techniques (OSET), which will take place between September 21-24 in Boston, Massachusetts, USA. The Orthopaedic Summit is a gathering of Total Joint (Knee, Hip, Shoulder), Foot & Ankle, Sports Medicine, Arthroscopic, Spine and Trauma Surgeons from the global orthopaedic industry.
The meeting is expected to host more than 1,000 delegates including medical professionals and industry representatives. Prof. Ryd is amongst an international faculty of over 350, that has been invited to participate in an interactive case panel discussion and present on the Episealer® implant technology during the meeting’s “Coming Soon To Your Neighborhood: The Cartilage Invaders” section.
“Year after year, the Orthopaedic Summit meeting continues to strengthen its reputation as one of the “can’t miss” orthopaedic events on the calendar. Surgeons love its fast-paced, intellectually challenging environment, and we are delighted that Professor Ryd is amongst this year’s faculty”, said Patrick Jamnik, President of Episurf Medical, Inc.
“It is a great pleasure to return to the Orthopaedic Summit faculty. This meeting’s commitment to presenting novel solutions to help treat everyday orthopaedic challenges is unsurpassed. The format and faculty of this meeting help ensure that delegates walk away with not only a sense of today’s standards of care, but also what to expect from the future. It’s been interesting to see this meeting grow in importance over the years”, said Prof. Leif Ryd, Medical Advisor, Episurf Medical.
The Episealer® Knee implant is in the US an investigational device, limited by US law to investigational use only.
More information to be found at: https://orthosummit.com/
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags: